17 Feb 2022
An appetite-suppressing drug that mimics glucagon-like peptide-1 (GLP-1) has been approved by the National Institute for Health and Care Excellence (NICE) for NHS patients with a BMI of over 35 and at least one weight-related condition.
BSPED Research and Innovation Award 2024 now open
03 May 2024
Nurse and Allied Health Professionals Award 2024 – applications now open
03 May 2024
Committee opportunity: Clinical Standards Officer
03 May 2024
Updated: UK Paediatric Endocrine Standards
03 May 2024
BSPED and RCPCH statement on puberty blockers for central precocious puberty
03 May 2024